首页 | 本学科首页   官方微博 | 高级检索  
检索        


Current comprehensive assessment and management of women at increased risk for breast cancer
Authors:Hollingsworth Alan B  Singletary S Eva  Morrow Monica  Francescatti Darius S  O'Shaughnessy Joyce A  Hartman Anne-Renee  Haddad Becky  Schnabel Freya R  Vogel Victor G
Institution:a Department of Surgery, Mercy Health Center, Mercy Women's Center, 4300 McAuley Blvd., Oklahoma City, OK 73120, USA
b Department of Surgery, MD Anderson Cancer Center, Houston, TX, USA
c Department of Surgery, Northwestern University, Chicago, IL, USA
d Department of Surgery, Rush Medical College, Chicago, IL, USA
e Baylor-Sammons Cancer Center, US Oncology, Dallas, TX, USA
f Department of Medicine, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA
g Susan G. Komen Foundation, Dallas, TX, USA
h Department of Surgery, Columbia Presbyterian Medical Center, New York, NY, USA
i Department of Medicine, University of Pittsburgh, Pittsburgh, PA, USA
Abstract:The potential for reducing the risk of breast cancer through selective estrogen receptor modulators, aromatase inhibitors, and surgery has generated interest in the use of quantitative models of risk assessment. With the addition of ductal lavage cytology to traditional epidemiologic risk factors, a discovery of cellular atypia can result in refinement of assigned risk values, while simultaneously optimizing patient selection for selective estrogen receptor modulators utilization. In view of increasing complexity in this arena, a Risk Assessment Working Group was formed to outline management strategies for the patient at an elevated risk for the development of breast cancer. No longer a statistical exercise, quantitative risk assessment is part of basic breast care and comprehensive management includes a discussion of the following: ductal lavage for improved risk stratification, multiple options for risk reduction, and high risk surveillance strategies that might incorporate investigational imaging protocols.
Keywords:Breast cancer  Risk assessment  Ductal lavage  Hormone replacement therapy  Risk management strategy  Chemoprevention  Magnetic resonance imaging
本文献已被 ScienceDirect PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号